<DOC>
	<DOCNO>NCT02342977</DOCNO>
	<brief_summary>The purpose study determine effect lacosamide reduce amount pain medication need follow total hip arthroplasty . The study team hypothesize single dose lacosamide reduce amount pain medication require surgery . The study team plan evaluate amount pain medication need quality pain control subject 's hospital stay three month follow-up visit follow surgery .</brief_summary>
	<brief_title>Effects Lacosamide Post-operative Opioid Requirements After Total Hip Arthroplasty :</brief_title>
	<detailed_description>All patient agree participate study receive surgical anesthetic technique provide patient undergoing procedure institution . Post-operative treatment therapy follow-up also patient undergoing procedure institution . The difference would patient would randomize ( determined chance , like flip coin ) either receive single dose lacosamide ( 100 mg mouth ) placebo ( sugar pill mouth ) surgical procedure . This would experimental part study . In addition , specific information collect throughout patient care discharge orthopedic clinic ( approximately 3 month procedure ) . The collected information include subject 's age , race ethnicity , sex , height , weight , American Society Anesthesiologist physical status , total amount opioid ( pain medication ) use , pain score , nausea vomiting , time spend post anesthesia care unit ( time discharge readiness ) , discharge hospital . The patient 's pain score opioid use assess follow-up approximately 3 month ( Note : specific information collect normally gather documented surgical patient ' record ) . In addition , participant may withdraw study time . The main goal study determine lacosamide reduce amount opioids require patient 's undergoing total hip arthroplasty . Lacosamide FDA approve medication treatment partial-onset seizure man-made amino acid ( usually use building block protein make body ) block special protein inby change electricity cell may feel ( voltage-gated sodium channel ) . Lacosamide new antiepileptic drug apparently lack major pharmacokinetic interaction ( body affect specific drug administration , well chemical change substance body , effect rout excretion metabolite drug ) . Lacosamide , carbamazepine oxcarbazepine know block special protein cover cell allow sodium cell turn change electricity cell may feel ( voltage-gated sodium channel , NaV1.7 ) . Lacosamide choose carbamazepine oxcarbazepine cause few side effect . Currently , lacosamide test patient painful diabetic nerve pain . Further trial identify lacosamide 's potential pain control indication start .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Lacosamide</mesh_term>
	<criteria>Patients eligible participation 1870 year age . Patients American Society Anesthesiologists physical status IIII . Patients schedule primary total hip arthroplasty . Any patient willing comply study requirement agree study . A patient 's refusal participate . Inability give consent . Any patient schedule opioid regimen pain great 3 month . Bleeding diathesis . Hypersensitivity lacosamide component formulation ( formulation contain phenylalanine ) and/or drug allergy medication use study . Second thirddegree atrioventricular ( AV ) block , sick sinus syndrome without pacemaker , sodium channelopathies ( e.g. , Brugada syndrome ) , myocardial ischemia , heart failure , structural heart disease . Severe hepatic renal impairment . Pregnant become pregnant . BreastFeeding . Have suicidal thought , depression , behavioral change . Taking antiepileptic medication . Any known seizure disorder ( e.g . LennoxGastaut syndrome ) . Currently prescribe : Carbamazepine Strong inhibitor cytochrome P4502C9 ( Capecitabine ; Delavirdine ; floxuridine ; Fluorouracil ( Systemic ) ; Gemfibrozil ; Nicardipine ; Sitaxentan ; Sulfadiazine ; Sulfissoxazole ; Tegafur ; Tolbutamide ) Strong inhibitor cytochrome P4503A4 ( Atazanavir ; Boceprevir ; Chloramphenicol ; Clarithromycin ; Cobicistat ; Conivaptan ; Darunavir ; Delavirdine ; Fosamprenavir ; Indinavir ; Itraconazole ; Ketoconazole ( Systemic ) ; Lopinavir ; Nefazodone ; Nelfinavir ; Nicardipine ; Posaconazole ; Ritonavir ; Saquinavir ; Telaprevir ; Telithromycin ; Voriconazole ) Delavirdine Fosphenytoin Nicardipin Phenobarbital Phenytoin Ethinylestradiol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>total hip arthroplasty</keyword>
</DOC>